L’Oréal gains access to skin stim
This article was originally published in The Rose Sheet
Executive Summary
L'Oréal breaks into the skin-care device market through a partnership with Light BioScience, a developer of non-invasive GentleWaves LED (Light Emitting Diode) Photomodulation "used by physicians and medical spas around the world to reduce wrinkles and improve skin." Announced Dec. 12, the scientific collaboration allows for the co-development of skin-care stimulation devices based on Light BioScience's proprietary technology and extends L'Oréal the opportunity for future worldwide marketing of devices already developed by Light BioScience. "We have decided to pool our in-depth knowledge of skin ... to offer consumers a new and complementary approach to skin care," L'Oréal Executive VP-R&D Jean-Francois Grollier states. The French beauty firm will create a unit for "instrumental cosmetics" within its Research and Development Division
You may also be interested in...
Gentle Waves intellectual property for sale
The intellectual property portfolio for Gentle Waves LED (Light Emitting Diode) Photomodulation System is for sale, trade broker ICAP Ocean Tomo announces. Gentle Waves, "scientifically proven to reduce the appearance of fine lines and wrinkles," was developed by Light Bioscience and was part of a marketing partnership with L'Oréal (1"The Rose Sheet" Dec. 17, 2007). The portfolio includes 60 U.S. and worldwide issued and pending patents as well as regulatory approvals, trademarks, logos, and related assets. The technology would likely be of interest to any company competing in the beauty and cosmeceutical market, estimated to generate $70 billion in sales in 2009, ICAP says
PerriconeMD skin-care device
Cosmeceutical marketer has launched Light Renewal treatment consisting of light emitting diode (LED) device and company's Nourishing Milky Cleanser and Serum prep to ensure skin receives optimum benefit. "While light therapy has long proven effective in fighting the signs of age, up until now it has been expensive and not easily accessible," says PerriconeMD, which teamed with Photo Therapeutics to bring the technology to the consumer market. In a 12-week clinical trial, 84% of participants reported improvement in skin-tone appearance, and 83% reported softening in the appearance of fine lines and wrinkles. The system costs $335 on the company's Web site. Photo Therapeutics is being acquired by PhotoMedex under a deal signed in August and expected to close in the fourth quarter of 2008; the two firms recently announced that Photo Therapeutics' hand-held Omnilux LED-based device for reduction of fine lines and peri-orbital wrinkles will roll out to nearly 600 CVS/pharmacy locations this fall. L'Oreal is another personal-care firm pursuing LED skin rejuvenation, having partnered with Light BioScience, the developer of non-invasive GentleWaves LED Photomodulation, in 2007 (1"The Rose Sheet" Dec. 17, 2007, In Brief)
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”